Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mitsugu Fujita has a total of 370 co-authors. Here are the top co-authors by number of shared publications:

  • Hideho Okada

    Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA

    12 shared publications
  • Gary Kohanbash

    Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, USA

    11 shared publications
  • Kimihiro Yamashita

    Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe, Japan

    8 shared publications
  • Ryo Ueda

    Authors' Affiliations: 1Department of Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health; 2Brain Tumor Program, University of Pittsburgh Cancer Institute, Hillman Cancer Center; Departments of 3Neurological Surgery, 4Surgery, and 5Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and 6Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota

    8 shared publications
  • Xinmei Zhu

    Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

    8 shared publications
  • Masasuke Ohno

    Department of Neurosurgery, Aichi Cancer Center, 1-1 Shikanodono, Chikusa-ku, Nagoya 464-8681, Aichi, Japan

    7 shared publications

Latest Publications

  • Open Access

    Role of Free Fatty Acid Receptor 2-Expressing Macrophages in Fibrotic Interstitial Lung Disease—Preliminary Study of Spatial Proximity to Stromal and Epithelial Cells in Lungs

    by Osamu Nishiyama, Mitsugu Fujita, Toru Nagasaka, Masasuke Ohno, Hisako Matsumoto

    Fibrotic interstitial lung disease (f-ILD) progresses at variable rates, and bulk cell densities discard the spatial information behind that variation. Free fatty acid receptor 2 (FFAR2) senses microbial short-chain fatty acids (SCFAs) and restrains macrophage inflammation, but its position in the human fibrotic lung remains unknown. We tested position rather than abundance. In cryobiopsy specimens from 10 patients with fibrotic idiopathic interstitial pneumonia, we combined chromogenic multiplex immunohistochemistry for FFAR2/Iba1 and CD163/Iba1 with deep learning-based image cytometry, mapped single-cell coordinates, and scored each subset’s proximity to stromal cells and the alveolar epithelium with three indices, including the colocalization index (CLI). Proximity of FFAR2-positive macrophages to stromal cells correlated with the 1-year change in forced vital capacity (FVC) (CLI: ρ=0.80, pρ=0.83, pρ=0.87, p<0.01). CD163-positive macrophages showed no such association with FVC, and no index correlated with baseline lung function. In this preliminary cohort, the position of FFAR2-positive macrophages, not their abundance, marks a protective niche and nominates the SCFA-FFAR2 axis as a therapeutic target in f-ILD.

  • Open Access

    Spatial Architecture of B7-H3-Expressing Cell Subpopulations Predicts Patient Prognosis in Lung Cancer Brain Metastases: A Pilot Study

    by Shigeaki Nawa, Mitsugu Fujita, Masasuke Ohno, Shunichiro Kuramitsu, Shota Nohira, Ryuta Saito

    Background: The clinical outcomes of lung cancer brain metastases (LCBMs) are highly variable. Traditional pathology relies on bulk cell densities. These static measures fail to capture the spatial architecture of the tumor immune microenvironment (TIME). B7-H3 (CD276) represents a key immune checkpoint in LCBMs. We investigated whether the spatial orchestration of B7-H3-expressing cell populations is associated with patient prognosis. Methods: Multiplex immunohistochemistry (mIHC) for B7-H3 and Iba1 (a macrophage marker) was performed on surgically resected tissues from 22 patients, with single-cell segmentation and classification in QuPath. We then applied spatial point pattern and spatial autocorrelation analyses to evaluate the relative positioning of single cells, computing spatial interaction metrics, including cross-Moran’s I and the cross-K function, within a 35 μm radius. These metrics were correlated with postoperative overall survival (OS), and prognostic thresholds were determined via time-dependent ROC curve analysis. Results: Standard cell densities generally did not correlate with OS, although B7-H3+ tumor-associated macrophage (TAM) density showed a moderate positive correlation (rs=0.434, p = 0.044), of a magnitude comparable to the clinical GPA score (rs=0.464, p = 0.029). Conversely, specific spatial metrics emerged as candidate prognostic factors. High spatial mixing and clustering of B7-H3+ and B7-H3− TAMs, as shown by high cross-Moran’s I (p = 0.011) and the cross-K function (p = 0.033), associated with significantly shorter OS. This pattern suggests a coordinated local immunosuppressive network. Conversely, high spatial integration between B7-H3+ and B7-H3− tumor cells was associated with prolonged OS (p = 0.016), whereas spatial segregation of B7-H3+ tumor cells was associated with poor outcomes. Conclusions: Decoding the spatial architecture of B7-H3-expressing cell subpopulations provides superior prognostic stratification compared with standard density-based metrics. These localized spatial niches represent potential biomarkers and therapeutic targets for personalized LCBM management.

  • Open Access

    Spatial Architecture of B7-H3-Expressing Cell Subpopulations Predicts Patient Prognosis in Lung Cancer Brain Metastases: A Pilot Study

    by Shigeaki Nawa, Mitsugu Fujita, Masasuke Ohno, Shunichiro Kuramitsu, Shota Nohira, Ryuta Saito

    Background: The clinical outcomes of lung cancer brain metastases (LCBMs) are highly variable. Traditional pathology relies on bulk cell densities. These static measures fail to capture the spatial architecture of the tumor immune microenvironment (TIME). B7-H3 (CD276) represents a key immune checkpoint in LCBMs. We investigated whether the spatial orchestration of B7-H3-expressing cell populations predicts patient prognosis. Methods: We performed multiplex immunohistochemistry (mIHC) for B7-H3 and Iba1 (a macrophage marker) in surgically resected tissues from 22 patients. We used QuPath for single-cell segmentation and classification. We performed spatial point pattern and spatial autocorrelation analyses to evaluate the relative positioning of single cells. We computed spatial interaction metrics, which included cross-Moran’s I and the cross-K function, within a 35 μm radius. We correlated these metrics with postoperative overall survival (OS) and determined prognostic thresholds via time-dependent ROC curve analysis. Results: Standard cell densities generally did not correlate with OS, although B7-H3+ tumor-associated macrophage (TAM) density showed a positive correlation. Conversely, specific spatial metrics served as significant prognostic factors. High spatial mixing and clustering of B7-H3+ and B7-H3- TAMs, as shown by high cross-Moran’s I (p = 0.011) and the cross-K functions (p = 0.033), correlated with significantly shorter OS. This pattern suggests a coordinated local immunosuppressive network. Conversely, high spatial integration between B7-H3+ and B7-H3- tumor cells correlated with prolonged OS (p = 0.016), whereas spatial segregation of B7-H3+ tumor cells predicted poor outcomes. Conclusions: Decoding the spatial architecture of B7-H3-expressing cell subpopulations provides superior prognostic stratification compared with standard density-based metrics. These localized spatial niches represent potential biomarkers and therapeutic targets for personalized LCBM management.

  • Open Access

    Paquinimod Targeting of the S100A8/A9 Axis Suppresses Liver Metastasis in Aged Mice

    by Takao Tsuneki, Masafumi Saito, Kimihiro Yamashita, Masayuki Ando, Keisuke Yasuda, Naoto Shirakami, Ryota Ito, Yukari Adachi, Hiroki Kagiyama, Takaaki Tachibana, et al.

    Backgrou nd: Aging profoundly alters host immunity, yet how age-associated immune changes in the liver influence the growth of metastatic tumors remains incompletely understood. Liver metastasis is a major cause of cancer-related mortality, particularly in elderly patients, for whom aggressive treatments are often not feasible. This study aimed to clarify how aging reshapes the hepatic immune microenvironment and to identify age-associated host factors that influence liver metastasis growth. Methods: Tumor-naïve and tumor-bearing young and aged mice were analyzed using a syngeneic MC38 liver metastasis model. Immune cell composition in the liver was assessed by flow cytometry, and gene expression was evaluated by quantitative reverse transcription PCR (RT–qPCR). Public transcriptomic datasets were screened to identify age-associated inflammatory factors. The functional relevance of the S100A8/A9 axis was examined using the small-molecule inhibitor paquinimod. Results: Aging was associated with a distinct baseline immune cell composition in the liver. During liver metastasis, overall growth was comparable between young and aged mice; however, metastatic lesions in aged hosts showed increased expression of multiple inflammation-related genes and prominent accumulation of Ly6G+ cells. In silico screening identified S100a9 as one of the most highly upregulated inflammation-related genes in aged livers, which was confirmed in both tumor-naïve and metastatic liver tissues. Pharmacological modulation of the S100A8/A9 axis with paquinimod significantly reduced liver metastasis growth in aged, but not young, mice, and was accompanied by a shift in immune cell composition, including an increased representation of CD8+ T cells. Conclusions: These findings indicate that aging is associated with a distinct hepatic immune context that shapes the inflammatory and cellular composition of the tumor microenvironment during liver metastasis. S100A9 emerges as a key age-associated, host-derived factor that is functionally relevant to the growth of liver metastases in aged hosts, supporting the S100A8/A9 axis as a context-specific therapeutic target.

  • Open Access

    Association of Iba1-Positive Macrophages and B7-H3-Positive Tumor Cells with Tumor Growth Kinetics in WHO Grade II Meningioma: A Pilot Watch-and-Wait Cohort Study

    by Eiji Ito, Masasuke Ohno, Mao Yokota, Shunichiro Kuramitsu, Toru Nagasaka, Toshiaki Inomo, Tadashi Watanabe, Mitsugu Fujita

    Background/Objectives: WHO grade II meningiomas show highly variable growth rates that are difficult to predict using conventional histology. We investigated relationships between immune components within the tumor immune microenvironment (TIME) and explored their association with tumor growth kinetics. Methods: We retrospectively evaluated a small, preselected cohort of 15 patients with WHO grade II meningiomas who underwent initial “watch-and-wait” observation with serial preoperative MRI. Notably, this cohort represents a specific clinical subset—tumors deemed initially observable—and may not be representative of all WHO grade II meningiomas. Densities of Iba1-positive macrophages (TAMs) and B7-H3-positive tumor cells were quantified by digital pathology. The relative growth rate (RGR) was calculated from serial MRI. Results: A strong inverse correlation was observed between TAM density and B7-H3-positive tumor cell density (Spearman’s R = −0.921, p < 0.001). Individual immune components did not show significant linear correlations with RGR; on median-split stratification, high B7-H3-positive tumor cell density was associated with a nominally significant difference in RGR (p = 0.0428, unadjusted). Low TAM density showed a non-significant trend in the same direction. Conclusions: Our findings generate the hypothesis that WHO grade II meningiomas exhibit an inverse relationship between TAMs and B7-H3 and that macrophage-poor/B7-H3-high and macrophage-rich/B7-H3-low patterns may differ in preoperative growth behavior. These observations are derived from a small, preselected cohort of tumors managed with an initial “watch-and-wait” strategy and require validation in broader populations.


  • Open Access

    Association of Iba1-Positive Macrophages and B7-H3-Positive Tumor Cells with Tumor Growth Kinetics in WHO Grade II Meningioma

    by Eiji Ito, Masasuke Ohno, Mao Yokota, Shunichiro Kuramitsu, Toru Nagasaka, Toshiaki Inomo, Tadashi Watanabe, Mitsugu Fujita

    Background/Objectives: WHO grade II meningiomas exhibit heterogeneous clinical behavior that cannot be predicted by conventional histology. This study examined the relationship between the tumor immune microenvironment (TIME) and tumor growth kinetics in order to establish a biological basis for more precise risk stratification. Methods: A retrospective cohort of 15 patients was evaluated. Serial preoperative magnetic resonance imaging (MRI) scans were used to calculate the relative growth rate (RGR) and minimize the baseline tumor size. The densities of Iba1-positive macrophages (TAMs) and B7-H3-positive tumor cells were quantified using a deep learning-based image analysis system. Results: Linear correlation analysis showed no significant associations between individual immune components and RGR. However, median-based stratification revealed distinct associations. Tumors with low TAM density or high B7-H3-positive tumor cell density exhibited significantly higher RGR (P = 0.0401). Additionally, a significant inverse relationship was identified between TAM and that of B7-H3-positive tumor cell densities (Spearman’s R = -0.911, P < 0.001). Conclusions: We identified a proliferative "immune-cold" phenotype in WHO grade II meningiomas, which is characterized by low TAM density and high B7-H3-positive tumor cell density. This study extends established molecular frameworks by suggesting that high B7-H3-positive tumor cells proactively contribute to rapid tumor growth. These findings highlight the importance of targeting B7-H3-positive tumor cells when treating malignant meningiomas.

  • Open Access

    Characterization of Tumor Immune Microenvironment in Meningiomas: Correlation of Tumor-infiltrating Lymphocyte Aggregates With Tumor Grade

    by Toshiaki Inomo, Masasuke Ohno, Toru Nagasaka, Shunichiro Kuramitsu, Eiji Ito, Tadashi Watanabe, Mitsugu Fujita

    Background/Aim: Malignant meningiomas are aggressive intracranial tumors with high recurrence rates and limited treatment options. The tumor immune microenvironment (TIME) plays a pivotal role in the tumor progression and treatment response. However, its role in meningioma remains largely unknown. This study aimed to analyze tumor-infiltrating lymphocytes (TILs) within the meningioma TIME and investigate their correlation with clinical parameters. Patients and Methods: Using tumor specimens from patients diagnosed with meningioma (grade 1, 12 cases; grade 2, 10 cases), the densities of CD4+ T-cells, CD8+ T-cells, CD20+ B-cells, and tissue-resident memory T-cells were quantified using multicolor immunohistochemistry and the QuPath software. The results were analyzed along with clinical parameters, including tumor grades. Results: The density of individual TIL subsets did not correlate with the tumor grades or patients’ postoperative neurological function. TIL aggregates were observed in grade 2 meningiomas; clusters of abundant B-cells with a few follicular helper T-cells were observed in one case, indicating the presence of immature tertiary lymphoid structures. A positive correlation was observed between the densities of CD4+ and CD8+ T-cells in grade 2 meningiomas but not in grade 1. Conclusion: The TIME in meningiomas exhibits distinct immune profiles by tumor grade, characterized by the presence of TIL aggregates and coordinated CD4+ and CD8+ T-cell infiltration in higher-grade tumors. These findings may provide insights into the immune landscape of meningiomas and support the development of immunotherapeutic strategies targeting the TIME.


  • Open Access

    Tumor-Infiltrating B Cells and Tissue-Resident Memory T Cells as Prognostic Indicators in Brain Metastases Derived from Gastrointestinal Cancers

    by Masasuke Ohno, Shunichiro Kuramitsu, Kimihiro Yamashita, Toru Nagasaka, Shoichi Haimoto, Mitsugu Fujita

    Background/Objectives: Tumor-infiltrating B cells (TIBs) and tissue-resident memory T cells (TRMs) play significant roles in antitumor immunity. However, their prognostic relevance in brain metastases (BMs) derived from gastrointestinal (GI) cancers remains unclear. This study aimed to investigate the prognostic significance of TIBs and TRMs in GI cancer-derived BMs (GIBMs). Methods: Retrospective histopathological analyses were performed on surgically resected GIBM tissues from 13 patients. The densities of tumor-infiltrating lymphocytes (TIL) subsets (TIBs, CD4+ T cells, CD8+CD103+ TRMs, and CD8+CD103- non-TRMs) were quantified and correlated with clinical parameters and overall survival (OS) including the Graded Prognostic Assessment (GPA). Results: TIBs and CD4+ T cells were predominantly accumulated in the tumor stroma, particularly around blood vessels, where they formed lymphocyte clusters without characteristics of tertiary lymphoid structures (TLSs). In contrast, TRMs more deeply infiltrated into the tumor epithelium than their counterpart non-TRMs. Positive correlations were found between TIB density and both the prognostic prediction of GPA and overall survival (OS) after BM diagnosis or surgery. Furthermore, increased densities of TIBs and TRMs were associated with enhanced survival after BM diagnosis. Conclusions: TIB and TRM densities in BM tissues could serve as reliable prognostic indicators for survival in patients with GIBMs. This study provides crucial insights for the development of novel immunotherapeutic strategies against this lethal disease.


  • Open Access

    Tertiary Lymphoid Structures in Brain Metastases of Lung Cancer: Prognostic Significance and Correlation With Clinical Outcomes

    by Shota Nohira, Shunichiro Kuramitsu, Masasuke Ohno, Mitsugu Fujita, Kimihiro Yamashita, Toru Nagasaka, Shoichi Haimoto, Noriaki Sakakura, Hirokazu Matsushita, Ryuta Saito

    Background/Aim: The prognosis of patients with brain metastases (BMs) originating from lung cancer remains poor, despite advancements in treatment strategies. The role of tertiary lymphoid structures (TLSs) within the tumor immune microenvironment of BMs has not been extensively explored. Patients and Methods: This study utilized patient-derived clinical samples from 17 patients with histologically confirmed BMs of lung cancer, undergoing surgical resection. Immunohistochemistry was employed to analyze the presence and characteristics of TLS and tumor-infiltrating lymphocytes (TILs) within BM tissues, correlating these with clinical outcomes. Results: TLSs, albeit in their immature form, were identified within BM tissues, distinguishing them from their mature counterparts in primary lung cancer tissues. A significant correlation between TLS density (but not TIL density) and improved postoperative survival was observed, underscoring the potential of TLS density as an independent prognostic marker. Furthermore, TLS density did not correlate with the Graded Prognostic Assessment (GPA) index, suggesting its unique prognostic value beyond conventional predictors. Conclusion: Our findings reveal the presence of TLSs in lung cancer-derived BMs and highlight their prognostic significance, independent of the GPA index. The identification of TLS within the unique central nervous system tumor microenvironment offers new insights into the immune landscape of BMs and suggests potential avenues for immunotherapeutic interventions targeting these structures to improve patient outcomes.


  • Open Access

    Clinical Significance of Early Venous Filling Detected via Preoperative Angiography in Glioblastoma

    by Kotaro Tatebayashi, Noriyuki Nakayama, Daisuke Sakamoto, Tomoko Iida, Shun Ono, Ikuo Matsuda, Yukiko Enomoto, Michihiro Tanaka, Mitsugu Fujita, Seiichi Hirota, et al.

    Preoperative angiography in glioblastoma (GBM) often shows arteriovenous shunts and early venous filling (EVF). Here, we investigated the clinical implications of EVF in GBM as a prognostic and vascular mimicry biomarker. In this retrospective multicenter study, we consecutively enrolled patients who underwent angiography with a GBM diagnosis between 1 April 2013 and 31 March 2021. The primary and secondary endpoints were the differences in overall survival (OS) and progression-free survival (PFS), respectively, between cases with and without EVF. Of the 133 initially enrolled patients, 91 newly diagnosed with GBM underwent preoperative angiography and became the study population. The 6-year OS and PFS were significantly worse in the EVF than in the non-EVF group. Moreover, 20 GBM cases (10 with EVF and 10 without EVF) were randomly selected and evaluated for histological vascular mimicry. Except for two cases that were difficult to evaluate, the EVF group had a significantly higher frequency of vascular mimicry than the non-EVF group (0/8 vs. 5/10, p = 0.04). EVF on preoperative angiography is a robust prognostic biomarker for GBM and may help detect cases with a high frequency of histological vascular mimicry.